Saudi Arabia Veterinary Pharmaceuticals Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

Saudi Arabia Veterinary Pharmaceuticals Market Overview

• The Saudi Arabia Veterinary Pharmaceuticals Market is valued at USD 35 million, based on a five-year historical analysis of dedicated veterinary pharmaceuticals revenue within the broader animal health sector. This growth is primarily driven by increasing pet ownership, rising livestock production, and heightened awareness of animal health, supported by a growing number of veterinary clinics and pharmacies across the country. The demand for veterinary pharmaceuticals has surged due to the growing need for effective disease management and preventive care in both companion and production animals, alongside rising investments in animal health infrastructure and services.
• Key cities such as Riyadh, Jeddah, and Dammam dominate the market due to their significant population density and concentration of veterinary services. These urban centers are also located within regions that have a strong presence of commercial livestock, poultry, and camel farming, which further drives the demand for veterinary pharmaceuticals. The presence and expansion of established veterinary clinics, hospitals, and specialized veterinary pharmacies in these regions enhance accessibility to veterinary care and support higher consumption of veterinary drugs and vaccines.
• In 2023, the Saudi Food and Drug Authority (SFDA) continued to strengthen the regulatory framework for veterinary pharmaceuticals, requiring all veterinary medicinal products to be registered and to undergo safety, quality, and efficacy evaluation before marketing authorization, in line with the Executive Regulation for Veterinary Products issued under the Saudi Food and Drug Authority Law and related SFDA veterinary product registration guidelines. This regulation framework aims to ensure the quality of veterinary products available in the market by setting requirements for dossier submission, GMP-compliant manufacturing, labeling, pharmacovigilance, and import controls, thereby enhancing animal health and safety standards across the country.

Saudi Arabia Veterinary Pharmaceuticals Market Segmentation

By Product Type:The market is segmented into various product types, including Pharmaceuticals, Vaccines, Medicated Feed Additives, Nutraceuticals & Supplements, and Others, consistent with the broader veterinary medication structure reported for Saudi Arabia. Pharmaceuticals, particularly anti-infectives and anti-parasitics, dominate the market due to their essential role in treating bacterial, parasitic, and inflammatory conditions in both companion and livestock animals. The increasing prevalence and awareness of zoonotic and production-limiting diseases, along with emphasis on food safety and productivity, are driving the demand for these products and supporting higher utilization of prescription veterinary drugs.

By Route of Administration:The market is further segmented by the route of administration, which includes Injectable, Oral, Topical, Auricular, Ophthalmic, and Nasal, and Others, in line with Saudi Arabia veterinary pharmaceuticals segmentation published by major industry studies. Injectable products are the most preferred route due to their rapid onset of action, higher bioavailability, and effectiveness in delivering medications for systemic infections, vaccines, and emergency treatments in both farm and companion animals. The convenience, dosing flexibility, and owner compliance associated with oral formulations also contribute to their substantial share, while topical and specialty routes (auricular, ophthalmic, nasal) are increasingly used for targeted therapies in small animals.

Saudi Arabia Veterinary Pharmaceuticals Market Competitive Landscape

The Saudi Arabia Veterinary Pharmaceuticals Market is characterized by a dynamic mix of regional and international players. Leading participants such as Zoetis Inc., Merck Animal Health (Merck & Co., Inc.), Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Bayer AG (Animal Health legacy portfolio), Ceva Santé Animale, Virbac, Vetoquinol SA, Dechra Pharmaceuticals plc, Phibro Animal Health Corporation, Neogen Corporation, PetIQ, Inc., Montajat Veterinary Pharmaceuticals Co. Ltd., Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO), Salehiya Healthcare contribute to innovation, geographic expansion, and service delivery in this space, supplying a range of vaccines, anti-infectives, parasiticides, and other therapeutics to both companion and production animal segments in Saudi Arabia.

Saudi Arabia Veterinary Pharmaceuticals Market Industry Analysis

Growth Drivers

• Increasing Pet Ownership:The pet population in Saudi Arabia has surged to approximately 2.5 million, reflecting a growing trend in pet ownership. This increase is driven by urbanization and changing lifestyles, with 60% of households now owning pets. As pet owners become more aware of the importance of veterinary care, the demand for veterinary pharmaceuticals is expected to rise significantly, contributing to market growth. The pet care expenditure is projected to reach SAR 1.2 billion in future, further supporting this trend.
• Rising Livestock Production:Saudi Arabia's livestock sector is projected to produce over 1.5 million tons of meat in future, driven by government initiatives to enhance food security. The livestock population, including sheep, goats, and cattle, has increased by 10% since 2020. This growth necessitates a corresponding rise in veterinary pharmaceuticals to ensure animal health and productivity. The government's investment of SAR 1 billion in livestock health programs further underscores the importance of veterinary products in this expanding sector.
• Growing Awareness of Animal Health:Awareness campaigns and educational programs have led to a significant increase in the understanding of animal health among farmers and pet owners. In future, approximately 70% of livestock owners reported using veterinary services regularly, up from 50% in 2020. This shift is expected to drive the demand for veterinary pharmaceuticals, as stakeholders recognize the benefits of preventive care and timely treatment. The government's focus on animal welfare and health education is projected to enhance this trend further.

Market Challenges

• Regulatory Hurdles:The veterinary pharmaceuticals market in Saudi Arabia faces significant regulatory challenges, including stringent approval processes for new drugs. The Ministry of Environment, Water, and Agriculture has implemented complex regulations that can delay product launches by up to 18 months. This regulatory environment can deter investment and innovation in the sector, limiting the availability of new veterinary products and hindering market growth. Compliance costs can also be a burden for smaller companies.
• High Cost of Veterinary Drugs:The cost of veterinary pharmaceuticals in Saudi Arabia has risen sharply, with some essential drugs increasing by 25% over the past two years. This price escalation poses a challenge for both pet owners and livestock farmers, who may struggle to afford necessary treatments. The high costs can lead to under-treatment of animals, negatively impacting overall animal health and productivity. This situation creates a barrier to accessing quality veterinary care, particularly in rural areas.

Saudi Arabia Veterinary Pharmaceuticals Market Future Outlook

The future of the veterinary pharmaceuticals market in Saudi Arabia appears promising, driven by increasing pet ownership and livestock production. The integration of technology in veterinary practices, such as telemedicine, is expected to enhance service delivery and accessibility. Additionally, the focus on preventive healthcare will likely lead to higher demand for veterinary products. As the market evolves, stakeholders must navigate regulatory challenges while capitalizing on emerging trends to ensure sustainable growth and improved animal health outcomes.

Market Opportunities

• Expansion of Veterinary Clinics:The number of veterinary clinics in Saudi Arabia is projected to increase by 15% in future, driven by rising pet ownership and livestock health needs. This expansion presents opportunities for pharmaceutical companies to establish partnerships with clinics, ensuring a steady demand for veterinary products and services. Enhanced access to veterinary care will likely improve animal health outcomes and increase the overall market size.
• Growth in E-commerce for Veterinary Products:The e-commerce sector for veterinary products is expected to grow significantly, with online sales projected to reach SAR 500 million in future. This growth is fueled by changing consumer preferences and the convenience of online shopping. Companies that invest in digital platforms can tap into this expanding market, providing easier access to veterinary pharmaceuticals and enhancing customer engagement through targeted marketing strategies.